An audit of transfusion reaction monitoring and reporting at a cancer hospital in Pakistan- a step towards hemovigilance

Author(s):  
Muhammad Hasan ◽  
Imran Ahmed Siddiqui ◽  
Zahid Qamar ◽  
Asad Hayat ◽  
Admin

Abstract Objective: To monitor the frequencies of different adverse transfusion reactions and to assess the compliance of clinical staff with the process of sending proper transfusion reaction workup within the specified time. Methods: The retrospective audit was conducted at the blood bank of Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan, and comprised all transfusion reaction forms received from July 1, 2017, to June 30, 2018. The forms were analysed for type of blood component, time in which it was received by thw blood bank, whether or not the form was completely filled, whether or not all required samples were provided, and the type of reaction. Results: Of the 12,787 units dispensed and transfused, 50(0.39%) transfusion reactions were noted. Allergic was the most frequent type 24(48%). Red cells accounted for 38(76%) of the reactions. In 58(95%) cases, reaction forms were completely filled. Blood bags in 36(59%) and post-transfusion ethylenediaminetetraacetic acid samples in 35(57.3%) cases were received at blood bank within 2 hours of reaction. Conclusion: Incidence of transfusion reactions was found to be low as there was good compliance with procedures on the part of the clinical staff. Key Words: Transfusion reactions, Haemo-vigilance, Clinical audit.

2020 ◽  
Vol 7 (12) ◽  
pp. A576-581
Author(s):  
Suzaan Shajil ◽  
Deepa Sowkur Anandarama Adiga ◽  
Debarshi Saha ◽  
Shrijeet Chakraborty ◽  
Ranjitha Rao

Background: Adequate and safe transfusion facility of blood and its components is necessary as blood transfusions are a part of life saving measures in medical and surgical emergencies. However, transfusion practice could result in non-fatal to fatal adverse transfusion reactions (ATR). Therefore, it is important to identify various adverse reactions so that steps can be taken to minimize such reactions and ensure safer transfusion being carried out. Methods: All ATRs reported to the blood bank from January 2013 to December 2016 were reviewed and analysed. The frequency of ATRs and its association with various component types were assessed. Result: During the study period, a total of 199106 units of blood were issued from the blood bank out of which there was an incidence of 77 (0.12%) transfusion reactions. Chills/rigors was the most common symptom (27.3%) of the symptomatic cases followed by pruritis (23.4%) Majority of the transfusion reaction were non haemolytic, 76 (98.7%) cases. One case was of haemolytic transfusion reaction. Among the non-haemolytic transfusion reactions, febrile non haemolytic transfusion reaction (FNHTR) constituted 28 (36.4%) and allergic reactions constituted 41(53.2%). Other transfusion reactions including hypotensive transfusion reaction (HTR), 1 (1.3%) case and transfusion associated dyspnoea (TAD), 6 (7.8%) cases were also seen. The frequency of ATRs was highest with packed red cells (PC) being 75.3% and least with platelet concentrate (PLTC) being 11.7%. Conclusion: The frequency of ATRs in our blood bank was found to be on a lower scale when compared to that of most of the similar studies. Allergic reactions and FNHTR were the most common ATRs seen, introduction of leukoreduction filters would help reduce FNHTRs.


2012 ◽  
Vol 65 (1-2) ◽  
pp. 50-53 ◽  
Author(s):  
Jasmina Grujic ◽  
Zdravko Gulan ◽  
Zorana Budakov

Introduction. Application of blood and blood components throughout decades is very successful and mostly safe procedure in patients? therapy. However, it may lead to unfavourable effects, such as transfusion reactions. Material and Methods. In the period from 2000 to 2009, 180 transfusion reactions were reported at the Department of Clinical Transfusion of the Service for Blood Transfusion of Vojvodina in Novi Sad. The aetiology of transfusion reactions was determined by examining pretransfusion and post-transfusion sample of patient?s blood and by examining the unit of blood component that induced reaction. Results. Out of 180 reported transfusion reactions, 98 (54.4%) were febrile non-haemolytic transfusion reactions, 69 (38.3%) allergic reactions and 2 (1.11%) haemolytic reactions. Blood components that caused most of transfusion reactions were erythrocytes (62.4%), fresh frozen plasma (11.2%) and platelets (14.4%). All patients underwent multiple transfusions. Discussion. The fact that only 0.13% transfusion reactions were reported, compared with data from literature (2-15%), points to the lack of regular reporting of transfusion reactions, as well as the fact that there is only one report of delayed transfusion reaction. Conclusions. To improve and make blood transfusion safer it is necessary to respect all pre-transfusion procedures, constant follow up of blood transfusion must be done and patients with diagnosed non-haemolytic transfusion reaction should be given leukocyte reduced blood components.


Author(s):  
Eko Putri Rahajeng ◽  
Raehana Samad ◽  
Rachmawati Muhiddin

Blood transfusion is an important part of health care. A blood transfusion can be carried out after careful consideration of its risks and benefits. One of the important considerations for blood transfusion is adverse transfusion reaction. Several risk factors for a transfusion reaction are age, gender, repeated transfusion, disease diagnosis, type of blood component, and blood incompatibility. This research is a descriptive study performed at Blood Bank Dr. Wahidin Sudirohusodo Hospital, Makassar, from January to December 2017. The subjects were all patients reported to have an acute transfusion, totaling 104 subjects. The descriptive method was carried out by the calculation of frequency distribution. From January to December 2017, 104 patients with transfusion reactions were obtained, predominantly were male (53.8%), with the lowest age range of ≥ 60 years (27.9%), packed red cell as the most found blood components (82.4%), a history of previous transfusion reactions (72.1%), and a diagnosis of malignancy (53.9%). The history of repeated transfusions is the most common risk factor compared to age, gender, blood component, and patient diagnosis.


Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 4831-4831
Author(s):  
John Clark Henegan ◽  
Mohamed Ayman Asfour

Introduction An immediate transfusion reaction may be suspected in a patient experiencing new or a change in symptoms while receiving blood products. The patient's acute clinical change often warrants halting the transfusion and alerting the blood bank to the possibility of a transfusion reaction. In an effort to better understand the patient, transfusion, and clinical characteristics of these acute events we reviewed all of the transfusion reaction alerts submitted over one year at an academic medical center. Methods Transfusion reaction alerts submitted for the previous year to the blood bank at an academic medical center were compiled. Delayed serologic reactions were excluded in an effort to focus on immediate transfusion reactions. The charts associated with these events (n=48) were reviewed and details regarding patient, transfusion component, and clinical characteristics were recorded. In addition, the reaction's final classification after review by an experienced blood bank pathologist was noted. Results Of the 48 transfusion reaction alerts, 56% involved a patient with any type of previously documented allergy. Event notes associated with the suspected transfusion reaction indicated that: o 51% involved a dermatologic symptom (e.g. edema, erythema, maculopapular changes, pruritus) o 32% included a respiratory symptom (e.g. dyspnea, wheezing) o 16% included a constitutional symptom (e.g. chills, fever, rigors, diaphoresis, pain) o 16% included a neurological symptom (e.g. dizziness, lethargy, agitation) There was no concordance between the five alerted reactions that found new onset, post transfusion hemoglobinemia and the seven alerted reactions that demonstrated new onset, post transfusion hemogloburia. Significant findings included o Persons < 18 years of age were more likely to have an alert that involved a dermatologic symptom than another type of symptom (RR: 2.8, 1.6-4.2, p= 0.001). o IR APH platelets were more likely to have an alert that involved a dermatologic symptom than another type of symptom (RR: 2.56, 1.4-4.8, p=0.003). o A temperature increase of > 2 °F had: µ A significant increased associated with reactions classified as febrile nonhemolytic reactions (RR: 4.1, 1.6-10.4, p=0.003) µ A significant decreased association with a reactions classified as allergic reactions (RR: 0.22, 0.05-0.90, p=0.03). After review by an experienced blood bank pathologist, no acute hemolytic transfusion reactions were found to have occurred in the past year. Conclusions This review of immediate transfusion reactions has a number of significant limitations including: · Being a retrospective review from a single center · Involving a small sample size · Lack of any acute hemolytic transfusion reactions as determined by an experienced blood bank pathologist · Relying on univariate analysis to detect significant findings · Lack of a formal method to detect ascertainment bias Despite these limitations, these findings may spark future work related to: · The prevalence of documented allergies (56%) in patients with an acute transfusion reaction alert is significantly higher than a previously reported rate of 21% of hospitalized patients with documented allergies of any type (Gonzales-Gregori et al. 2012). · The concordance between post transfusion hemoglobinuria and hemoglobinemia in transfusion reactions as there was no concordance between these two laboratory tests in this study. · Validating that a recorded temperature rise of > 2 F can be used at the bedside to determine if an immediate transfusion reaction is a febrile nonhemolytic reaction and not an allergic reaction. Disclosures: No relevant conflicts of interest to declare.


2020 ◽  
Vol 3 (02) ◽  
pp. 35-38
Author(s):  
Md. Jaki Yamani ◽  
Md. Golzar Hossain ◽  
Md. Ashraful Haque Chowdhury ◽  
Md. Imran Hossain ◽  
Mohammed Murad Hossain ◽  
...  

Background: Transfusion of blood products is one of the principle components of supportive management in patients with acute leukaemia. Objective: The purpose of this study was to observe the pattern of adverse transfusion reactions (ATR) in acute leukaemia patients receiving blood component therapy. Methodology: This observational study was conducted in the Department of Haematology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh from January 2018 to December 2018. Total ninety-five diagnosed case of Acute Myeloid Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL) patients were selected for the study. Results: Four types of transfusion reactions including Febrile Non-Haemolytic Transfusion Reaction (FNHTR), Allergic, Anaphylactic, Delayed Haemolytic Transfusion Reaction (DHTR) were detected by clinical observations and relevant laboratory investigations. In this study, 25 (26.3%) patients showed different types of adverse transfusion reactions. Allergic reactions (48%) found to be the most common followed by FNHTR (32%), anaphylactic reactions (16%) and DHTR (4%). Allergic reactions (58.34%) were predominant in platelet transfusion and febrile reactions (62.5%) observed in red cell concentrate (RCC) transfusion. Urticaria, pruritus, angioedema, breathlessness, stridor, shivering, hypotension were prominent symptoms in allergic and anaphylactic reactions. On the other hand, fever, chills and rigors were prominent symptoms in case of febrile non haemolytic transfusion reaction. In our study no association between transfusion reaction with age, sex, types of donor, types of platelet and unit of transfusion was found. ATRs are mostly non-severe but rarely cause severe transfusion reaction. Conclusion: For safe blood transfusion close monitoring of transfusion, early recognition of pattern of reaction and prompt action may decrease transfusion related adverse events.


2019 ◽  
pp. 1-6
Author(s):  
Bepasha Naznin ◽  
Md. Ashraful Hoque* ◽  
Daanish Arefin Biswas ◽  
Tamanna Afroz ◽  
Farida Parvin ◽  
...  

Background:Allergic transfusion reactions (ALTR) are very common complication of blood transfusion. Advances in transfusion medicine have significantly decreased the incidence of ALTR; however, ALTR continue to be burdensome for transfusion dependent patients. It increases their existing sufferings. Allergic reaction is more common in platelet concentrate transfusion because stored platelet concentrate supernatants (PCSNs) accumulate striking levels of biological response modifiers (BRMs) during storage. Objective: To determine the risk factors of allergic reactions in platelate concentrate transfusion. Method: It is a case control study enrolled a total of 64 diagnosed case of aplastic anaemia receiving transfusion of platelet concentrate at Department of Transfusion Medicine, BSMMU, Dhaka, from May 2015 to April 2016. Among them 32 case of aplastic anaemia having allergic reaction due to transfusion of platelet concentrate was considered as group I (case) and rest 32 patients not developed allergic transfusion reaction due to transfusion of platelet concentrate was considered as group II (control). Patients age belong to 5 - 50 years and both sex and also patients getting transfusion of plate late concentrate were enrolled in this study. Statistical analysis: Statistical analyses were carried out by using the Statistical Package for Social Sciences version 20.0 for Windows (SPSS Inc., Chicago, Illinois, USA). Chi-Square test, Odds ratio with 95% CI used to analyze the categorical variables, shown with cross tabulation. Student ttest used for continuous variables. Significant value of 'p' was decided to be at a level of 0.05 in two tailed tests. Result: The mean age was found 22.1±11.58 years in group I and 23.5±3.8 years in group II. Twenty four (75.0%) patients were male in group I and 17(53.1%) patients in group II. Almost twenty (62.5%) patients come from urban area in group I and 19(59.4%) in group II. In group I, thirty two (100.0%) patients had urticarialrash, 100.0% had itching, 37.5% had angioedema, 3.1% had cough, 3.1% had chest pain, 3.1% had respiratory distress, 3.1% had fever and 3.1% had vomiting. Almost twenty(62.5%) patients had tachycardia (>100 bpm) in group I and all patients had normal pulse in group II.Thirty two (100.0%) patients had normal blood pressure in both group. In group I, 31(96.9%) patients developed mild allergic reaction, 3.1% moderate allergic reaction. Majority (40.6%) patients belonged to age 16-30 years in present allergic transfusion reaction and 11(34.3%) in absent allergic transfusion reaction. Most (40.6%) of the patients was found blood group B in present allergic transfusion reaction and 11(34.4%) in absent allergic transfusion reaction. Multiple unit of PC transfusion increases 3.69 times risk to develop allergic transfusion reactions with 95% CI 0.99 to 14.44%.Platelet concentrate storage>3daysincreases 5.95timesrisktodevelopallergic transfusionreactionwith95%CI1.75to21.09%. Conclusion: Multiple unit (≥2) transfusion and Platelet concentrate storage >3 days were significantly (p<0.05) associated with allergic transfusion reactions but no significant association was found between allergic transfusion reactions with age and Blood group


2014 ◽  
Vol 2014 ◽  
pp. 1-3 ◽  
Author(s):  
Eva Spada ◽  
Arianna Miglio ◽  
Daniela Proverbio ◽  
Maria Teresa Antognoni ◽  
Giada Bagnagatti De Giorgi ◽  
...  

Data from potential feline blood donors presented at two university blood banks in Italy were recorded. Blood typing was performed using an immunochromatographic method. Over the three years of the study 357 cats representing 15 breeds, 45.3% female and 54.7% male, with a mean age of 3.8 years were evaluated. Of these 90.5% were blood type A, 5.6% type B, and 3.9% type AB. The majority of the cats (54.6%) were European DSH (92.3% were type A, 5.1% type B, and 2.6% type AB), and 21% were Maine Coon (MCO) cats (100% blood type A). The estimated frequencies of transfusion reactions following an unmatched transfusion between DSH (donors and recipients), MCO (donor and recipients), DSH donors and MCO recipients, and MCO donors and DSH recipients were 4.8%, 0%, 0%, and 5.1% for major reactions and 7.2%, 0%, 7.7%, and 0% for minor transfusions reactions, respectively. In a population of blood donors that includes DSH and MCO the risk of transfusion reaction is between 5% and 8% if typing is not performed on donor and recipient blood. Blood typing should therefore be performed before transfusion to remove the risk of transfusion reactions due to blood type incompatibilities.


PEDIATRICS ◽  
1961 ◽  
Vol 27 (3) ◽  
pp. 370-372
Author(s):  
Robert D. Gens

A patient who had received multiple blood transfusions and whose serum exhibited a leukocyte agglutinin is reported. This patient developed transfusion reactions characterized by chills, fever and lethargy when administered routine bloodbank and leukocyte-rich blood. No transfusion reaction was noted when the patient received leukocyte-poor blood.


2002 ◽  
Vol 126 (8) ◽  
pp. 909-914 ◽  
Author(s):  
David A. Novis ◽  
Richard C. Friedberg ◽  
Stephen W. Renner ◽  
Frederick A. Meier ◽  
Molly K. Walsh

Abstract Objectives.—To determine the normative distribution of time elapsed for blood bank personnel to fill nonscheduled operating room (OR) blood component orders in hospital communities throughout the United States, and to examine hospital blood bank practices associated with faster blood component delivery times. Design.—Participants in the College of American Pathologists Q-Probes laboratory quality improvement program collected data prospectively on the times elapsed for blood bank personnel to fill nonscheduled emergent orders from hospital ORs for red blood cell (RBC) products, fresh frozen plasma (FFP), and platelets (PLTs). Participants also completed questionnaires describing their hospitals' and blood banks' laboratory and transfusion practices. Setting and Participants.—Four hundred sixty-six public and private institutions located in 48 states in the United States (n = 444), Canada (n = 9), Australia (n = 8), the United Kingdom (n = 4), and Spain (n = 1). Main Outcome Measures.—The median time elapsed between requests for blood components by OR personnel and the retrieval of those components by blood component transport personnel, and the median time elapsed between requests for blood components by OR personnel and the arrival of those components in ORs. Results.—Participants submitted data on 12 647 units of RBCs, FFP, and PLTs. The median aggregate request-to-retrieval turnaround times (TATs) for RBCs, FFP, and PLTs ranged from 30 to 35 minutes, and the median aggregate request-to-arrival TATs for RBCs, FFP, and PLTs ranged from 33 to 39 minutes. Most of the TAT was consumed by events occurring prior to, rather than after release of components from blood banks. Shorter prerelease TATs were associated with having surgical schedules that listed patients' names and procedures available to blood bank personnel prior to surgeries, and having adequate clotted specimens in the blood bank and completed type-and-screen procedures performed before requests for blood components were submitted to blood banks. Among the fastest-performing 10% of participants (90th percentile and above), request-to-retrieval TATs ranged from 12 to 24 minutes for the 3 blood components, whereas among the slowest-performing 10% of participants (10th percentile and below), request-to-retrieval TATs ranged from 63 to 115 minutes for the 3 components. Median TATs ranged from 33 to 37 minutes for the 3 components. Institutions with TATs in the fastest-performing 25th percentile more frequently stored cross-matched RBCs in the OR daily, stocked PLTs for unexpected surgical use, stored PLTs in or near the OR, and had laboratory rather than nonlaboratory personnel deliver components to the OR than did those institutions with TATs in the slowest-performing 25th percentile. Conclusions.—Hospital blood bank personnel can deliver blood components to the OR in slightly longer than 30 minutes, measured from the time that those units are requested by OR personnel. Practices aimed at saving time before components are released from blood banks will be more efficient in reducing overall TAT than those practices aimed at saving time after components are released from blood banks. Specific practices associated with shorter blood delivery TATs included providing blood bank personnel with access to the names of surgical patients potentially requiring blood components, having pretransfusion testing completed on those patients prior to surgery, having ample blood products on hand, and having laboratory personnel control blood product delivery.


Sign in / Sign up

Export Citation Format

Share Document